Company: PACB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001299130-25-000156
Chunk: 182

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 2
Chunk 182
---
 percentages)20252024$ Change% ChangeRevenue:Product revenue $33,083 $31,746 $1,337 4%Service and other revenue 6,683 4,267 2,416 57%Total revenue 39,766 36,013 3,753 10%Cost of Revenue:Cost of product revenue 20,022 23,083 (3,061)(13%)Cost of service and other revenue 4,853 3,366 1,487 44%Amortization of acquired intangible assets183 2,628 (2,445)(93%)Loss on purchase commitment24 998 (974)(98%)Total cost of revenue 25,082 30,075 (4,993)(17%)Gross profit14,684 5,938 8,746 147%Operating Expense:Research and development 22,529 38,485 (15,956)(41)%Sales, general and administrative 36,175 45,877 (9,702)(21)%Impairment charges— 93,200 (93,200)(100)%Amortization of acquired intangible assets833 4,222 (3,389)(80)%Total operating expense 59,537 181,784 (122,247)(67%)Operating loss (44,853)(175,846)130,993 (74)%Interest expense (1,738)(3,542)1,804 (51)%Other income, net 4,696 6,069 (1,373)(23%)Loss before income taxes(41,895)(173,319)131,424 (76%)Income tax provision35 — 35 — Net loss$(41,930)$(173,319)$131,389 (76%)

Q2 Fiscal 2025 Form 10-Q30

Revenue

Total Revenue

Total revenue increased $3.8 million, or 10%, for the second quarter of 2025 compared with the same quarter of 2024.Product revenue increased $1.3 million, or 4%, primarily due to an increase of $1.9 million, or 11%, in consumable revenue, partially offset by a decrease of $0.5 million, or 4%, in instrument revenue.Service and other revenue increased $2.4 million, or 57%, primarily driven by an increase in Revio service